Ludwig-Maximilians-Universität München, Klinikum Großhadern

1 results · Page 1 of 1

Swipe the table sideways for more columns.

Trial	Conditions	Status	Phase	Updated	More info	NCT ID
Trial to Evaluate Efficacy and Safety of Bortezomib in Patients With Severe Autoimmune Encephalitis	Neuroinflammatory Diseases, autoimmune disease, autoimmune disorder of the nervous system, autoimmune encephalitis, brain disorder, central nervous system disorder, encephalitis, immune system disorder, nervous system disorder	Recruiting	Phase 2	2025-09-04		NCT03993262

Clinical trials